Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion

Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2000-12, Vol.39 (51), p.16092-16098
Hauptverfasser: Huuskonen, Jarkko, Olkkonen, Vesa M, Ehnholm, Christian, Metso, Jari, Julkunen, Ilkka, Jauhiainen, Matti
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16098
container_issue 51
container_start_page 16092
container_title Biochemistry (Easton)
container_volume 39
creator Huuskonen, Jarkko
Olkkonen, Vesa M
Ehnholm, Christian
Metso, Jari
Julkunen, Ilkka
Jauhiainen, Matti
description Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods:  native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.
doi_str_mv 10.1021/bi0019287
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_bi0019287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c255582421</sourcerecordid><originalsourceid>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</originalsourceid><addsrcrecordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0dkk-3WU-tFCigHjedkmE7q1TeJuKvrvjaTUi6dhmId3eF5CLincUojo3dICUBVJcUTGlEUQJkqxYzIGAB5GisOInHm_7tcERHJKRpTSKFaxGJNZtmp8u2o2trVlkDtT-wpdMPeBCTKHDj921tsOg6pxQZbmWbjA0poOy2D2kAbTpv5E521Tn5OTymw8XuznhLw9PebTWZi-PM-n92lo4kR1YcWlZDyhCEoAY7JQPEKBCVOwFJUpAaRisQJuiqKXEjE1xnCgFDmTEot4Qm6G3MI13jusdOvs1rhvTUH_tqEPbfTs1cC2u-UWyz9yr98D4QBY3-HX4W7cu-YiFkzn2WsfuqCQSKWnPX898Kbwet3sXN2r_vP4B-Gfchk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><source>MEDLINE</source><source>ACS Publications</source><creator>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</creator><creatorcontrib>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</creatorcontrib><description>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods:  native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi0019287</identifier><identifier>PMID: 11123937</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino Acid Substitution - genetics ; Apolipoprotein A-I - antagonists &amp; inhibitors ; Apolipoprotein A-I - metabolism ; Biological Transport - drug effects ; Biological Transport - genetics ; Carrier Proteins - antagonists &amp; inhibitors ; Carrier Proteins - chemistry ; Carrier Proteins - genetics ; Carrier Proteins - physiology ; Diethyl Pyrocarbonate - pharmacology ; Dose-Response Relationship, Drug ; Humans ; Lipoproteins, HDL - metabolism ; Membrane Proteins - antagonists &amp; inhibitors ; Membrane Proteins - chemistry ; Membrane Proteins - genetics ; Membrane Proteins - physiology ; Mutagenesis, Site-Directed ; Phospholipid Transfer Proteins ; Phospholipids - antagonists &amp; inhibitors ; Phospholipids - chemistry ; Phospholipids - metabolism ; Recombinant Proteins - chemistry ; Thimerosal - pharmacology</subject><ispartof>Biochemistry (Easton), 2000-12, Vol.39 (51), p.16092-16098</ispartof><rights>Copyright © 2000 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</citedby><cites>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi0019287$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi0019287$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11123937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huuskonen, Jarkko</creatorcontrib><creatorcontrib>Olkkonen, Vesa M</creatorcontrib><creatorcontrib>Ehnholm, Christian</creatorcontrib><creatorcontrib>Metso, Jari</creatorcontrib><creatorcontrib>Julkunen, Ilkka</creatorcontrib><creatorcontrib>Jauhiainen, Matti</creatorcontrib><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods:  native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</description><subject>Amino Acid Substitution - genetics</subject><subject>Apolipoprotein A-I - antagonists &amp; inhibitors</subject><subject>Apolipoprotein A-I - metabolism</subject><subject>Biological Transport - drug effects</subject><subject>Biological Transport - genetics</subject><subject>Carrier Proteins - antagonists &amp; inhibitors</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - physiology</subject><subject>Diethyl Pyrocarbonate - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Membrane Proteins - antagonists &amp; inhibitors</subject><subject>Membrane Proteins - chemistry</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - physiology</subject><subject>Mutagenesis, Site-Directed</subject><subject>Phospholipid Transfer Proteins</subject><subject>Phospholipids - antagonists &amp; inhibitors</subject><subject>Phospholipids - chemistry</subject><subject>Phospholipids - metabolism</subject><subject>Recombinant Proteins - chemistry</subject><subject>Thimerosal - pharmacology</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0dkk-3WU-tFCigHjedkmE7q1TeJuKvrvjaTUi6dhmId3eF5CLincUojo3dICUBVJcUTGlEUQJkqxYzIGAB5GisOInHm_7tcERHJKRpTSKFaxGJNZtmp8u2o2trVlkDtT-wpdMPeBCTKHDj921tsOg6pxQZbmWbjA0poOy2D2kAbTpv5E521Tn5OTymw8XuznhLw9PebTWZi-PM-n92lo4kR1YcWlZDyhCEoAY7JQPEKBCVOwFJUpAaRisQJuiqKXEjE1xnCgFDmTEot4Qm6G3MI13jusdOvs1rhvTUH_tqEPbfTs1cC2u-UWyz9yr98D4QBY3-HX4W7cu-YiFkzn2WsfuqCQSKWnPX898Kbwet3sXN2r_vP4B-Gfchk</recordid><startdate>20001226</startdate><enddate>20001226</enddate><creator>Huuskonen, Jarkko</creator><creator>Olkkonen, Vesa M</creator><creator>Ehnholm, Christian</creator><creator>Metso, Jari</creator><creator>Julkunen, Ilkka</creator><creator>Jauhiainen, Matti</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20001226</creationdate><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><author>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Amino Acid Substitution - genetics</topic><topic>Apolipoprotein A-I - antagonists &amp; inhibitors</topic><topic>Apolipoprotein A-I - metabolism</topic><topic>Biological Transport - drug effects</topic><topic>Biological Transport - genetics</topic><topic>Carrier Proteins - antagonists &amp; inhibitors</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - physiology</topic><topic>Diethyl Pyrocarbonate - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Membrane Proteins - antagonists &amp; inhibitors</topic><topic>Membrane Proteins - chemistry</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - physiology</topic><topic>Mutagenesis, Site-Directed</topic><topic>Phospholipid Transfer Proteins</topic><topic>Phospholipids - antagonists &amp; inhibitors</topic><topic>Phospholipids - chemistry</topic><topic>Phospholipids - metabolism</topic><topic>Recombinant Proteins - chemistry</topic><topic>Thimerosal - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huuskonen, Jarkko</creatorcontrib><creatorcontrib>Olkkonen, Vesa M</creatorcontrib><creatorcontrib>Ehnholm, Christian</creatorcontrib><creatorcontrib>Metso, Jari</creatorcontrib><creatorcontrib>Julkunen, Ilkka</creatorcontrib><creatorcontrib>Jauhiainen, Matti</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huuskonen, Jarkko</au><au>Olkkonen, Vesa M</au><au>Ehnholm, Christian</au><au>Metso, Jari</au><au>Julkunen, Ilkka</au><au>Jauhiainen, Matti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2000-12-26</date><risdate>2000</risdate><volume>39</volume><issue>51</issue><spage>16092</spage><epage>16098</epage><pages>16092-16098</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods:  native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>11123937</pmid><doi>10.1021/bi0019287</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2000-12, Vol.39 (51), p.16092-16098
issn 0006-2960
1520-4995
language eng
recordid cdi_crossref_primary_10_1021_bi0019287
source MEDLINE; ACS Publications
subjects Amino Acid Substitution - genetics
Apolipoprotein A-I - antagonists & inhibitors
Apolipoprotein A-I - metabolism
Biological Transport - drug effects
Biological Transport - genetics
Carrier Proteins - antagonists & inhibitors
Carrier Proteins - chemistry
Carrier Proteins - genetics
Carrier Proteins - physiology
Diethyl Pyrocarbonate - pharmacology
Dose-Response Relationship, Drug
Humans
Lipoproteins, HDL - metabolism
Membrane Proteins - antagonists & inhibitors
Membrane Proteins - chemistry
Membrane Proteins - genetics
Membrane Proteins - physiology
Mutagenesis, Site-Directed
Phospholipid Transfer Proteins
Phospholipids - antagonists & inhibitors
Phospholipids - chemistry
Phospholipids - metabolism
Recombinant Proteins - chemistry
Thimerosal - pharmacology
title Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A01%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phospholipid%20Transfer%20Is%20a%20Prerequisite%20for%20PLTP-Mediated%20HDL%20Conversion&rft.jtitle=Biochemistry%20(Easton)&rft.au=Huuskonen,%20Jarkko&rft.date=2000-12-26&rft.volume=39&rft.issue=51&rft.spage=16092&rft.epage=16098&rft.pages=16092-16098&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi0019287&rft_dat=%3Cacs_cross%3Ec255582421%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11123937&rfr_iscdi=true